Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1998 Jul;53(7):601–612. doi: 10.1136/thx.53.7.601

Role of transcription factors in inflammatory lung diseases

I Rahman 1, W MacNee 1
PMCID: PMC1745272  PMID: 9797762

Full Text

The Full Text of this article is available as a PDF (187.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adcock I. M., Brown C. R., Barnes P. J. Tumour necrosis factor alpha causes retention of activated glucocorticoid receptor within the cytoplasm of A549 cells. Biochem Biophys Res Commun. 1996 Aug 14;225(2):545–550. doi: 10.1006/bbrc.1996.1209. [DOI] [PubMed] [Google Scholar]
  2. Adcock I. M., Lane S. J., Brown C. R., Lee T. H., Barnes P. J. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med. 1995 Dec 1;182(6):1951–1958. doi: 10.1084/jem.182.6.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Akira S., Kishimoto T. NF-IL6 and NF-kappa B in cytokine gene regulation. Adv Immunol. 1997;65:1–46. [PubMed] [Google Scholar]
  4. Albelda S. M., Smith C. W., Ward P. A. Adhesion molecules and inflammatory injury. FASEB J. 1994 May;8(8):504–512. [PubMed] [Google Scholar]
  5. Arenzana-Seisdedos F., Thompson J., Rodriguez M. S., Bachelerie F., Thomas D., Hay R. T. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol. 1995 May;15(5):2689–2696. doi: 10.1128/mcb.15.5.2689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baeuerle P. A., Baichwal V. R. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 1997;65:111–137. [PubMed] [Google Scholar]
  7. Baeuerle P. A., Baltimore D. NF-kappa B: ten years after. Cell. 1996 Oct 4;87(1):13–20. doi: 10.1016/s0092-8674(00)81318-5. [DOI] [PubMed] [Google Scholar]
  8. Baldwin A. S., Jr The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–683. doi: 10.1146/annurev.immunol.14.1.649. [DOI] [PubMed] [Google Scholar]
  9. Barnes P. J., Adcock I. M. NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci. 1997 Feb;18(2):46–50. doi: 10.1016/s0165-6147(97)89796-9. [DOI] [PubMed] [Google Scholar]
  10. Barnes P. J., Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci. 1993 Dec;14(12):436–441. doi: 10.1016/0165-6147(93)90184-l. [DOI] [PubMed] [Google Scholar]
  11. Barnes P. J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997 Apr 10;336(15):1066–1071. doi: 10.1056/NEJM199704103361506. [DOI] [PubMed] [Google Scholar]
  12. Beg A. A., Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 1996 Nov 1;274(5288):782–784. doi: 10.1126/science.274.5288.782. [DOI] [PubMed] [Google Scholar]
  13. Beg A. A., Finco T. S., Nantermet P. V., Baldwin A. S., Jr Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol. 1993 Jun;13(6):3301–3310. doi: 10.1128/mcb.13.6.3301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Beg A. A., Sha W. C., Bronson R. T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 1995 Jul 13;376(6536):167–170. doi: 10.1038/376167a0. [DOI] [PubMed] [Google Scholar]
  15. Bennett B. L., Cruz R., Lacson R. G., Manning A. M. Interleukin-4 suppression of tumor necrosis factor alpha-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-kappaB. J Biol Chem. 1997 Apr 11;272(15):10212–10219. doi: 10.1074/jbc.272.15.10212. [DOI] [PubMed] [Google Scholar]
  16. Beyaert R., Cuenda A., Vanden Berghe W., Plaisance S., Lee J. C., Haegeman G., Cohen P., Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 1996 Apr 15;15(8):1914–1923. [PMC free article] [PubMed] [Google Scholar]
  17. Blackwell T. S., Blackwell T. R., Holden E. P., Christman B. W., Christman J. W. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol. 1996 Aug 15;157(4):1630–1637. [PubMed] [Google Scholar]
  18. Blackwell T. S., Christman J. W. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol. 1997 Jul;17(1):3–9. doi: 10.1165/ajrcmb.17.1.f132. [DOI] [PubMed] [Google Scholar]
  19. Bowie A. G., Moynagh P. N., O'Neill L. A. Lipid peroxidation is involved in the activation of NF-kappaB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. Lack of involvement of H2O2 in NF-kappaB activation by either cytokine in both primary and transformed endothelial cells. J Biol Chem. 1997 Oct 10;272(41):25941–25950. doi: 10.1074/jbc.272.41.25941. [DOI] [PubMed] [Google Scholar]
  20. Brennan F. M., Maini R. N., Feldmann M. Cytokine expression in chronic inflammatory disease. Br Med Bull. 1995 Apr;51(2):368–384. doi: 10.1093/oxfordjournals.bmb.a072967. [DOI] [PubMed] [Google Scholar]
  21. Brostjan C., Anrather J., Csizmadia V., Natarajan G., Winkler H. Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. J Immunol. 1997 Apr 15;158(8):3836–3844. [PubMed] [Google Scholar]
  22. Cai Z., Körner M., Tarantino N., Chouaib S. IkappaB alpha overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-kappaB activation but not tumor necrosis factor-alpha-induced apoptosis. J Biol Chem. 1997 Jan 3;272(1):96–101. doi: 10.1074/jbc.272.1.96. [DOI] [PubMed] [Google Scholar]
  23. Chen C. C., Manning A. M. Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-kappa B. Agents Actions Suppl. 1995;47:135–141. doi: 10.1007/978-3-0348-7343-7_12. [DOI] [PubMed] [Google Scholar]
  24. Chen Z., Hagler J., Palombella V. J., Melandri F., Scherer D., Ballard D., Maniatis T. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 1995 Jul 1;9(13):1586–1597. doi: 10.1101/gad.9.13.1586. [DOI] [PubMed] [Google Scholar]
  25. Cheshire J. L., Baldwin A. S., Jr Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation. Mol Cell Biol. 1997 Nov;17(11):6746–6754. doi: 10.1128/mcb.17.11.6746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Choi H. S., Moore D. D. Induction of c-fos and c-jun gene expression by phenolic antioxidants. Mol Endocrinol. 1993 Dec;7(12):1596–1602. doi: 10.1210/mend.7.12.8145765. [DOI] [PubMed] [Google Scholar]
  27. Dalmasso F., Prota R. Snoring: analysis, measurement, clinical implications and applications. Eur Respir J. 1996 Jan;9(1):146–159. doi: 10.1183/09031936.96.09010146. [DOI] [PubMed] [Google Scholar]
  28. Demoly P., Chanez P., Pujol J. L., Gauthier-Rouvière C., Michel F. B., Godard P., Bousquet J. Fos immunoreactivity assessment on human normal and pathological bronchial biopsies. Respir Med. 1995 May;89(5):329–335. doi: 10.1016/0954-6111(95)90003-9. [DOI] [PubMed] [Google Scholar]
  29. DiDonato J. A., Hayakawa M., Rothwarf D. M., Zandi E., Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 1997 Aug 7;388(6642):548–554. doi: 10.1038/41493. [DOI] [PubMed] [Google Scholar]
  30. DiDonato J., Mercurio F., Rosette C., Wu-Li J., Suyang H., Ghosh S., Karin M. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol. 1996 Apr;16(4):1295–1304. doi: 10.1128/mcb.16.4.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Dolmetsch R. E., Lewis R. S., Goodnow C. C., Healy J. I. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature. 1997 Apr 24;386(6627):855–858. doi: 10.1038/386855a0. [DOI] [PubMed] [Google Scholar]
  32. Dröge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H. P., Roth S., Gmünder H. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 1994 Nov;8(14):1131–1138. [PubMed] [Google Scholar]
  33. Gess B., Schricker K., Pfeifer M., Kurtz A. Acute hypoxia upregulates NOS gene expression in rats. Am J Physiol. 1997 Sep;273(3 Pt 2):R905–R910. doi: 10.1152/ajpregu.1997.273.3.R905. [DOI] [PubMed] [Google Scholar]
  34. Ginn-Pease M. E., Whisler R. L. Optimal NF kappa B mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals. Biochem Biophys Res Commun. 1996 Sep 24;226(3):695–702. doi: 10.1006/bbrc.1996.1416. [DOI] [PubMed] [Google Scholar]
  35. Goldstone S. D., Fragonas J. C., Jeitner T. M., Hunt N. H. Transcription factors as targets for oxidative signalling during lymphocyte activation. Biochim Biophys Acta. 1995 Aug 22;1263(2):114–122. doi: 10.1016/0167-4781(95)00088-x. [DOI] [PubMed] [Google Scholar]
  36. Gupta S., Campbell D., Dérijard B., Davis R. J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 1995 Jan 20;267(5196):389–393. doi: 10.1126/science.7824938. [DOI] [PubMed] [Google Scholar]
  37. Haase M., Koslowski R., Lengnick A., Hahn R., Wenzel K. W., Schuh D., Kasper M., Müller M. Cellular distribution of c-Jun and c-Fos in rat lung before and after bleomycin induced injury. Virchows Arch. 1997 Dec;431(6):441–448. doi: 10.1007/s004280050121. [DOI] [PubMed] [Google Scholar]
  38. Haddad E. B., Salmon M., Koto H., Barnes P. J., Adcock I., Chung K. F. Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-kappa b in rat lung: inhibition by corticosteroids. FEBS Lett. 1996 Feb 5;379(3):265–268. doi: 10.1016/0014-5793(95)01524-8. [DOI] [PubMed] [Google Scholar]
  39. Hsu H., Xiong J., Goeddel D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell. 1995 May 19;81(4):495–504. doi: 10.1016/0092-8674(95)90070-5. [DOI] [PubMed] [Google Scholar]
  40. Isshiki H., Akira S., Tanabe O., Nakajima T., Shimamoto T., Hirano T., Kishimoto T. Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol Cell Biol. 1990 Jun;10(6):2757–2764. doi: 10.1128/mcb.10.6.2757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Jamaluddin M., Garofalo R., Ogra P. L., Brasier A. R. Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells. J Virol. 1996 Mar;70(3):1554–1563. doi: 10.1128/jvi.70.3.1554-1563.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Jany B., Betz R., Schreck R. Activation of the transcription factor NF-kappa B in human tracheobronchial epithelial cells by inflammatory stimuli. Eur Respir J. 1995 Mar;8(3):387–391. doi: 10.1183/09031936.95.08030387. [DOI] [PubMed] [Google Scholar]
  43. Jenster G., Spencer T. E., Burcin M. M., Tsai S. Y., Tsai M. J., O'Malley B. W. Steroid receptor induction of gene transcription: a two-step model. Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):7879–7884. doi: 10.1073/pnas.94.15.7879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Jin D. Y., Chae H. Z., Rhee S. G., Jeang K. T. Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem. 1997 Dec 5;272(49):30952–30961. doi: 10.1074/jbc.272.49.30952. [DOI] [PubMed] [Google Scholar]
  45. John M., Au B. T., Jose P. J., Lim S., Saunders M., Barnes P. J., Mitchell J. A., Belvisi M. G., Chung K. F. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol. 1998 Jan;18(1):84–90. doi: 10.1165/ajrcmb.18.1.2813. [DOI] [PubMed] [Google Scholar]
  46. Kazmi S. M., Plante R. K., Visconti V., Taylor G. R., Zhou L., Lau C. Y. Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J Cell Biochem. 1995 Feb;57(2):299–310. doi: 10.1002/jcb.240570214. [DOI] [PubMed] [Google Scholar]
  47. Keicho N., Elliott W. M., Hogg J. C., Hayashi S. Adenovirus E1A gene dysregulates ICAM-1 expression in transformed pulmonary epithelial cells. Am J Respir Cell Mol Biol. 1997 Jan;16(1):23–30. doi: 10.1165/ajrcmb.16.1.8998075. [DOI] [PubMed] [Google Scholar]
  48. Klement J. F., Rice N. R., Car B. D., Abbondanzo S. J., Powers G. D., Bhatt P. H., Chen C. H., Rosen C. A., Stewart C. L. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol. 1996 May;16(5):2341–2349. doi: 10.1128/mcb.16.5.2341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Koong A. C., Chen E. Y., Giaccia A. J. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res. 1994 Mar 15;54(6):1425–1430. [PubMed] [Google Scholar]
  50. Le Tulzo Y., Shenkar R., Kaneko D., Moine P., Fantuzzi G., Dinarello C. A., Abraham E. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression. J Clin Invest. 1997 Apr 1;99(7):1516–1524. doi: 10.1172/JCI119314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. LeVan T. D., Bloom J. W., Adams D. G., Hensel J. L., Halonen M. Platelet-activating factor induction of activator protein-1 signaling in bronchial epithelial cells. Mol Pharmacol. 1998 Jan;53(1):135–140. doi: 10.1124/mol.53.1.135. [DOI] [PubMed] [Google Scholar]
  52. Lee F. S., Hagler J., Chen Z. J., Maniatis T. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 1997 Jan 24;88(2):213–222. doi: 10.1016/s0092-8674(00)81842-5. [DOI] [PubMed] [Google Scholar]
  53. Lo Y. Y., Wong J. M., Cruz T. F. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem. 1996 Jun 28;271(26):15703–15707. doi: 10.1074/jbc.271.26.15703. [DOI] [PubMed] [Google Scholar]
  54. MacNee W., Rahman I. Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax. 1995 Sep;50 (Suppl 1):S53–S58. doi: 10.1136/thx.50.suppl_1.s53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Malinin N. L., Boldin M. P., Kovalenko A. V., Wallach D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 1997 Feb 6;385(6616):540–544. doi: 10.1038/385540a0. [DOI] [PubMed] [Google Scholar]
  56. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., Akira S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10193–10197. doi: 10.1073/pnas.90.21.10193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Mattila P. S., Ullman K. S., Fiering S., Emmel E. A., McCutcheon M., Crabtree G. R., Herzenberg L. A. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 1990 Dec;9(13):4425–4433. doi: 10.1002/j.1460-2075.1990.tb07893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. McDonald P. P., Bald A., Cassatella M. A. Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils. Blood. 1997 May 1;89(9):3421–3433. [PubMed] [Google Scholar]
  59. Meagher L. C., Cousin J. M., Seckl J. R., Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol. 1996 Jun 1;156(11):4422–4428. [PubMed] [Google Scholar]
  60. Metinko A. P., Kunkel S. L., Standiford T. J., Strieter R. M. Anoxia-hyperoxia induces monocyte-derived interleukin-8. J Clin Invest. 1992 Sep;90(3):791–798. doi: 10.1172/JCI115953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Mio T., Romberger D. J., Thompson A. B., Robbins R. A., Heires A., Rennard S. I. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med. 1997 May;155(5):1770–1776. doi: 10.1164/ajrccm.155.5.9154890. [DOI] [PubMed] [Google Scholar]
  62. Mizzen C. A., Yang X. J., Kokubo T., Brownell J. E., Bannister A. J., Owen-Hughes T., Workman J., Wang L., Berger S. L., Kouzarides T. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell. 1996 Dec 27;87(7):1261–1270. doi: 10.1016/s0092-8674(00)81821-8. [DOI] [PubMed] [Google Scholar]
  63. Moriguchi T., Toyoshima F., Masuyama N., Hanafusa H., Gotoh Y., Nishida E. A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses. EMBO J. 1997 Dec 1;16(23):7045–7053. doi: 10.1093/emboj/16.23.7045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Newberry E. P., Willis D., Latifi T., Boudreaux J. M., Towler D. A. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element. Mol Endocrinol. 1997 Jul;11(8):1129–1144. doi: 10.1210/mend.11.8.9958. [DOI] [PubMed] [Google Scholar]
  65. Ng K. W., Ridgway P., Cohen D. R., Tremethick D. J. The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome. EMBO J. 1997 Apr 15;16(8):2072–2085. doi: 10.1093/emboj/16.8.2072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Ogryzko V. V., Schiltz R. L., Russanova V., Howard B. H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 1996 Nov 29;87(5):953–959. doi: 10.1016/s0092-8674(00)82001-2. [DOI] [PubMed] [Google Scholar]
  67. Okamoto S., Mukaida N., Yasumoto K., Rice N., Ishikawa Y., Horiguchi H., Murakami S., Matsushima K. The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem. 1994 Mar 18;269(11):8582–8589. [PubMed] [Google Scholar]
  68. Olson E. N., Arnold H. H., Rigby P. W., Wold B. J. Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell. 1996 Apr 5;85(1):1–4. doi: 10.1016/s0092-8674(00)81073-9. [DOI] [PubMed] [Google Scholar]
  69. Packman L. C., Kubota K., Parker J., Gay N. J. Casein kinase II phosphorylates Ser468 in the PEST domain of the Drosophila IkappaB homologue cactus. FEBS Lett. 1997 Jan 2;400(1):45–50. doi: 10.1016/s0014-5793(96)01324-5. [DOI] [PubMed] [Google Scholar]
  70. Pahl H. L., Krauss B., Schulze-Osthoff K., Decker T., Traenckner E. B., Vogt M., Myers C., Parks T., Warring P., Mühlbacher A. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med. 1996 Apr 1;183(4):1829–1840. doi: 10.1084/jem.183.4.1829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Paliogianni F., Raptis A., Ahuja S. S., Najjar S. M., Boumpas D. T. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J Clin Invest. 1993 Apr;91(4):1481–1489. doi: 10.1172/JCI116353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Papavassiliou A. G. Molecular medicine. Transcription factors. N Engl J Med. 1995 Jan 5;332(1):45–47. doi: 10.1056/NEJM199501053320108. [DOI] [PubMed] [Google Scholar]
  73. Phillips R. J., Ghosh S. Regulation of IkappaB beta in WEHI 231 mature B cells. Mol Cell Biol. 1997 Aug;17(8):4390–4396. doi: 10.1128/mcb.17.8.4390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Rahman I., MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax. 1996 Apr;51(4):348–350. doi: 10.1136/thx.51.4.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Rahman I., Smith C. A., Lawson M. F., Harrison D. J., MacNee W. Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett. 1996 Oct 28;396(1):21–25. doi: 10.1016/0014-5793(96)01027-7. [DOI] [PubMed] [Google Scholar]
  76. Rao A., Luo C., Hogan P. G. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol. 1997;15:707–747. doi: 10.1146/annurev.immunol.15.1.707. [DOI] [PubMed] [Google Scholar]
  77. Read M. A., Whitley M. Z., Gupta S., Pierce J. W., Best J., Davis R. J., Collins T. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem. 1997 Jan 31;272(5):2753–2761. doi: 10.1074/jbc.272.5.2753. [DOI] [PubMed] [Google Scholar]
  78. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., Walter P., Yaffee M. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta. 1995 May 24;1271(1):67–74. doi: 10.1016/0925-4439(95)00012-s. [DOI] [PubMed] [Google Scholar]
  79. Régnier C. H., Song H. Y., Gao X., Goeddel D. V., Cao Z., Rothe M. Identification and characterization of an IkappaB kinase. Cell. 1997 Jul 25;90(2):373–383. doi: 10.1016/s0092-8674(00)80344-x. [DOI] [PubMed] [Google Scholar]
  80. Scheinman R. I., Cogswell P. C., Lofquist A. K., Baldwin A. S., Jr Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995 Oct 13;270(5234):283–286. doi: 10.1126/science.270.5234.283. [DOI] [PubMed] [Google Scholar]
  81. Schenk H., Klein M., Erdbrügger W., Dröge W., Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1672–1676. doi: 10.1073/pnas.91.5.1672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Schmidt K. N., Amstad P., Cerutti P., Baeuerle P. A. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem Biol. 1995 Jan;2(1):13–22. doi: 10.1016/1074-5521(95)90076-4. [DOI] [PubMed] [Google Scholar]
  83. Schulze-Osthoff K., Los M., Baeuerle P. A. Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem Pharmacol. 1995 Sep 7;50(6):735–741. doi: 10.1016/0006-2952(95)02011-z. [DOI] [PubMed] [Google Scholar]
  84. Schwartz M. D., Moore E. E., Moore F. A., Shenkar R., Moine P., Haenel J. B., Abraham E. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med. 1996 Aug;24(8):1285–1292. doi: 10.1097/00003246-199608000-00004. [DOI] [PubMed] [Google Scholar]
  85. Sen C. K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 1996 May;10(7):709–720. doi: 10.1096/fasebj.10.7.8635688. [DOI] [PubMed] [Google Scholar]
  86. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986 Aug 29;46(5):705–716. doi: 10.1016/0092-8674(86)90346-6. [DOI] [PubMed] [Google Scholar]
  87. Sha W. C., Liou H. C., Tuomanen E. I., Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell. 1995 Jan 27;80(2):321–330. doi: 10.1016/0092-8674(95)90415-8. [DOI] [PubMed] [Google Scholar]
  88. Shang F., Gong X., Taylor A. Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated. J Biol Chem. 1997 Sep 12;272(37):23086–23093. doi: 10.1074/jbc.272.37.23086. [DOI] [PubMed] [Google Scholar]
  89. Shea L. M., Beehler C., Schwartz M., Shenkar R., Tuder R., Abraham E. Hyperoxia activates NF-kappaB and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes. J Immunol. 1996 Nov 1;157(9):3902–3908. [PubMed] [Google Scholar]
  90. Shenkar R., Abraham E. Hemorrhage induces rapid in vivo activation of CREB and NF-kappaB in murine intraparenchymal lung mononuclear cells. Am J Respir Cell Mol Biol. 1997 Feb;16(2):145–152. doi: 10.1165/ajrcmb.16.2.9032121. [DOI] [PubMed] [Google Scholar]
  91. Sica A., Dorman L., Viggiano V., Cippitelli M., Ghosh P., Rice N., Young H. A. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem. 1997 Nov 28;272(48):30412–30420. doi: 10.1074/jbc.272.48.30412. [DOI] [PubMed] [Google Scholar]
  92. Simeonova P. P., Toriumi W., Kommineni C., Erkan M., Munson A. E., Rom W. N., Luster M. I. Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species. J Immunol. 1997 Oct 15;159(8):3921–3928. [PubMed] [Google Scholar]
  93. Spencer T. E., Jenster G., Burcin M. M., Allis C. D., Zhou J., Mizzen C. A., McKenna N. J., Onate S. A., Tsai S. Y., Tsai M. J. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature. 1997 Sep 11;389(6647):194–198. doi: 10.1038/38304. [DOI] [PubMed] [Google Scholar]
  94. Spergel J. M., Hsu W., Akira S., Thimmappaya B., Kishimoto T., Chen-Kiang S. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A. J Virol. 1992 Feb;66(2):1021–1030. doi: 10.1128/jvi.66.2.1021-1030.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Stacey M. A., Sun G., Vassalli G., Marini M., Bellini A., Mattoli S. The allergen Der p1 induces NF-kappaB activation through interference with IkappaB alpha function in asthmatic bronchial epithelial cells. Biochem Biophys Res Commun. 1997 Jul 18;236(2):522–526. doi: 10.1006/bbrc.1997.6997. [DOI] [PubMed] [Google Scholar]
  96. Stein B., Baldwin A. S., Jr, Ballard D. W., Greene W. C., Angel P., Herrlich P. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 1993 Oct;12(10):3879–3891. doi: 10.1002/j.1460-2075.1993.tb06066.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Thompson A. B., Robbins R. A., Romberger D. J., Sisson J. H., Spurzem J. R., Teschler H., Rennard S. I. Immunological functions of the pulmonary epithelium. Eur Respir J. 1995 Jan;8(1):127–149. doi: 10.1183/09031936.95.08010127. [DOI] [PubMed] [Google Scholar]
  98. Thompson J. E., Phillips R. J., Erdjument-Bromage H., Tempst P., Ghosh S. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell. 1995 Feb 24;80(4):573–582. doi: 10.1016/0092-8674(95)90511-1. [DOI] [PubMed] [Google Scholar]
  99. Toledano M. B., Leonard W. J. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4328–4332. doi: 10.1073/pnas.88.10.4328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Ura K., Kurumizaka H., Dimitrov S., Almouzni G., Wolffe A. P. Histone acetylation: influence on transcription, nucleosome mobility and positioning, and linker histone-dependent transcriptional repression. EMBO J. 1997 Apr 15;16(8):2096–2107. doi: 10.1093/emboj/16.8.2096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Verma I. M., Stevenson J. IkappaB kinase: beginning, not the end. Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11758–11760. doi: 10.1073/pnas.94.22.11758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Ward P. A. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann N Y Acad Sci. 1996 Oct 31;796:104–112. doi: 10.1111/j.1749-6632.1996.tb32572.x. [DOI] [PubMed] [Google Scholar]
  103. Whiteside S. T., Epinat J. C., Rice N. R., Israël A. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J. 1997 Mar 17;16(6):1413–1426. doi: 10.1093/emboj/16.6.1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Wilhelm D., Bender K., Knebel A., Angel P. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol Cell Biol. 1997 Aug;17(8):4792–4800. doi: 10.1128/mcb.17.8.4792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Wodrich W., Volm M. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis. 1993 Jun;14(6):1121–1124. doi: 10.1093/carcin/14.6.1121. [DOI] [PubMed] [Google Scholar]
  106. Wolfe S. A., Zhou P., Dötsch V., Chen L., You A., Ho S. N., Crabtree G. R., Wagner G., Verdine G. L. Unusual Rel-like architecture in the DNA-binding domain of the transcription factor NFATc. Nature. 1997 Jan 9;385(6612):172–176. doi: 10.1038/385172a0. [DOI] [PubMed] [Google Scholar]
  107. Woronicz J. D., Gao X., Cao Z., Rothe M., Goeddel D. V. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science. 1997 Oct 31;278(5339):866–869. doi: 10.1126/science.278.5339.866. [DOI] [PubMed] [Google Scholar]
  108. Xie Q. W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994 Feb 18;269(7):4705–4708. [PubMed] [Google Scholar]
  109. Xie W., Herschman H. R. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem. 1995 Nov 17;270(46):27622–27628. doi: 10.1074/jbc.270.46.27622. [DOI] [PubMed] [Google Scholar]
  110. Yang-Yen H. F., Chambard J. C., Sun Y. L., Smeal T., Schmidt T. J., Drouin J., Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 1990 Sep 21;62(6):1205–1215. doi: 10.1016/0092-8674(90)90396-v. [DOI] [PubMed] [Google Scholar]
  111. Yang X. J., Ogryzko V. V., Nishikawa J., Howard B. H., Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature. 1996 Jul 25;382(6589):319–324. doi: 10.1038/382319a0. [DOI] [PubMed] [Google Scholar]
  112. Zandi E., Rothwarf D. M., Delhase M., Hayakawa M., Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 1997 Oct 17;91(2):243–252. doi: 10.1016/s0092-8674(00)80406-7. [DOI] [PubMed] [Google Scholar]
  113. Zhang D. H., Cohn L., Ray P., Bottomly K., Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem. 1997 Aug 22;272(34):21597–21603. doi: 10.1074/jbc.272.34.21597. [DOI] [PubMed] [Google Scholar]
  114. Zhu Z., Tang W., Ray A., Wu Y., Einarsson O., Landry M. L., Gwaltney J., Jr, Elias J. A. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest. 1996 Jan 15;97(2):421–430. doi: 10.1172/JCI118431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Zünd G., Uezono S., Stahl G. L., Dzus A. L., McGowan F. X., Hickey P. R., Colgan S. P. Hypoxia enhances induction of endothelial ICAM-1: role for metabolic acidosis and proteasomes. Am J Physiol. 1997 Nov;273(5 Pt 1):C1571–C1580. doi: 10.1152/ajpcell.1997.273.5.C1571. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES